Publication | Open Access
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer
88
Citations
32
References
2018
Year
UrologyGenitourinary CancerMedicinePharmacologyPhase Ii StudyPharmacotherapyCancer TreatmentProstatic DiseaseOncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1